DBV Technologies Update
Montrouge, France, March 13, 2023
DBV Technologies Update
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), a clinical-stage biopharmaceutical company, informs its investors that it does not hold cash deposits or securities at Silicon Valley Bank.
About DBV Technologies
DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, and is DBV Technologies’ method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food-allergic patients. DBV Technologies’ food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France, and North American operations in Basking Ridge, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345) and the Company’s ADSs (each representing one-half of one ordinary share) are traded on the Nasdaq Global Select Market (Ticker: DBVT).
Forward Looking Statements
This press release may contain forward-looking statements and estimates, including statements regarding the therapeutic potential of Viaskin™ Peanut as a treatment for peanut-allergic children and the potential benefits of EPIT™, DBV Technologies’ clinical development and regulatory plans, timing and projections of VITESSE study milestones, and timing and anticipated results of interactions with regulatory agencies. All statements about VITESSE study milestones, enrollment and anticipated results contained herein are DBV’s best estimates and projections are based on performance of previous studies and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements with respect to the VITESSE study to differ materially from the estimates and projections contained herein. These forward-looking statements and estimates are not promises or guarantees and involve substantial risks and uncertainties and may be impacted by market conditions as well as other risks and uncertainties set forth in DBV Technologies’ regulatory filings with the Autorité des Marchés Financiers (“AMF”), DBV Technologies’ filings and reports with the U.S. Securities and Exchange Commission (“SEC”) and future filings and reports made with the AMF and SEC. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof. Other than as required by applicable law, DBV Technologies undertakes no obligation to update or revise the information contained in this Press Release.
Investor Contact
Anne Pollak
DBV Technologies
+1 857-529-2363
anne.pollak@dbv-technologies.com
Media Contact
Angela Marcucci
DBV Technologies
+1 646-842-2393
angela.marcucci@dbv-technologies.com
Viaskin and EPIT are trademarks of DBV Technologies.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
KBC Group: Dividend Announcement2.5.2024 18:00:00 CEST | Press release
REGULATED INFORMATION KBC GROUP Naamloze Vennootschap (company with limited liability) Havenlaan 2 - 1080 Brussels VAT BE 0403.227.515 (RPL Brussels) www.kbc.com DIVIDEND ANNOUNCEMENT Communication of 2 May 2024 at 18:00 The Annual General Meeting of 2 May 2024 has decided to pay a gross dividend of 4.15 euros per share for the financial year ending on 31 December 2023. Further to the payment of an interim dividend in the sum of 1 euro per share on 15 November 2023, the gross final dividend will be 3.15 euros per dividend entitled share (2.205 euros after the deduction of 30% withholding tax). Relevant dates are: Ex-coupon date: 13 May 2024Record date: 14 May 2024Pay date: 15 May 2024 Attachment 20240502-dividend-en
Bonduelle - Quarter 3 FY 2023-2024 Revenue: Business activity slightly down on Quarter 3 in a climate of constrained consumption2.5.2024 18:00:00 CEST | Press release
BONDUELLE Head office: "La Woestyne" - 59173 Renescure - France Bonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 euros Registered under number : 447 250 044 (Dunkerque Commercial and Companies Register) Quarter 3 FY 2023-2024 Revenue Bonduelle Group: Business activity slightly down on Quarter 3 in a climate of constrained consumption The Bonduelle Group's revenue stands for Quarter 3 of FY 2023-2024 (from January 1, to March 31, 2024) at 564.9 million euros, thus a downturn compared with the previous fiscal year (572.2 million euros) of -1.3% on reported figures and -1.0% on a like-for-like basis*. No change in the scope of consolidation occurred over the period. Over the 9 first months, the revenue amounted to 1,778.0 million euros, down -2.1% on reported figures and up +2.8% on a like-for-like basis* after taking into account currency variations (significant depreciation of the ruble and weakening of the US dollar against the euro compared with
Eik fasteignafélag hf.: Interim results for the first three months of 20242.5.2024 17:56:42 CEST | Press release
The Interim Consolidated Financial Statements of Eik fasteignafélag hf. for the period 1 January to 31 March 2024 were approved by the Company’s Board of Directors and CEO on 2 May 2024 The main results are as follows: Income from operations amounted to ISK 2,709 million Thereof, rental income amounted to ISK 2,365 millionEBITDA amounted to ISK 1,700 millionTotal profit amounted to ISK 2,051 million.Net cash from operations amounted to ISK 1,011 million.The book value of investment properties amounted to ISK 135,656 million. The book value of assets for own use amounted to ISK 5,956 millionChange in value of investment properties amounted to ISK 2,734 million.Cash and cash equivalents amounted to ISK 1,623 million.Interest-bearing debt amounted to ISK 77,191 million.Equity ratio was 35.0%.Profit per share was ISK 0.6.Economic occupancy rate was 93.8%Weighted indexed interest was 3.33%.Weighted unindexed interest was 6.26%. Attached is an interim financial report which contains Interim
AKVA group ASA: Minutes from annual general meeting2.5.2024 17:41:01 CEST | Press release
The annual general meeting of AKVA group ASA was held today, 2 May 2024. The minutes from the meeting are attached to this notice and will be made available on the company's website, https://www.akvagroup.com/investors/general-meeting/ All items on the agenda were approved in accordance with the proposals set out in the notice of the annual general meeting. For further information, please contact: Knut Nesse Chief Executive Officer Phone: +47 51 77 85 00 Mobile: +47 91 37 62 20 E-mail: knesse@akvagroup.com Ronny Meinkøhn Chief Financial Officer Phone: +47 51 77 85 00 Mobile: +47 98 20 67 76 E-mail: rmeinkohn@akvagroup.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments Minutes from annual general meeting 2024Protokoll fra ordinaer generalforsamling 2024
Kvika banki hf.: Financial Results for Q1 20242.5.2024 17:35:00 CEST | Press release
At a board meeting on 2 May 2024, the Board of Directors and the CEO approved the interim financial statements of the Kvika banki hf. (“Kvika” or “the bank”) group for the period 1 January to 31 March 2024. In Kvika’s financial statements for the period the insurance subsidiary TM tryggingar hf. (“TM”) is classified as held for sale. As a result, and in accordance with international financial reporting standards, the Group reports income from its insurance operations in a single line in the consolidated income statement as profit after tax from discontinued operations. The comparative figures of operations from 2023 have been restated accordingly. Highlights of the 3M 2024 Interim Financial Statements: Pre-tax profit, excluding TM insurance, amounted to ISK 1,215 million in Q1 2024, compared to ISK 895 million in Q1 2023 and increases by 36% from previous year.Post-tax profit of the group amounted to ISK 1,083 million in Q1 2024, compared to ISK 1,167 million in Q1 2023 and decreases b